191 related articles for article (PubMed ID: 1618233)
41. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
Lim JK; Mathias CJ; Green MA
J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338
[TBL] [Abstract][Full Text] [Related]
42. A remote system for the synthesis of copper-62 labeled Cu(PTSM).
Mathias CJ; Margenau WH; Brodack JW; Welch MJ; Green MA
Int J Rad Appl Instrum A; 1991; 42(3):317-20. PubMed ID: 1647386
[No Abstract] [Full Text] [Related]
43. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia.
Taniuchi H; Fujibayashi Y; Yonekura Y; Konishi J; Yokoyama A
J Nucl Med; 1997 Jul; 38(7):1130-4. PubMed ID: 9225805
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.
Ackerman LJ; West DX; Mathias CJ; Green MA
Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194
[TBL] [Abstract][Full Text] [Related]
45. The effects of glutathione depletion on the biodistribution of Cu(PTSM) in rats.
Barnhart-Bott A; Green MA
Int J Rad Appl Instrum B; 1991; 18(8):865-9. PubMed ID: 1800462
[TBL] [Abstract][Full Text] [Related]
46. Manganese-52m, a new short-lived, generator-produced radionuclide: a potential tracer for positron tomography.
Atcher RW; Friedman AM; Huizenga JR; Rayudu GV; Silverstein EA; Turner DA
J Nucl Med; 1980 Jun; 21(6):565-9. PubMed ID: 6966681
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM.
Beanlands RS; Muzik O; Hutchins GD; Wolfe ER; Schwaiger M
J Nucl Cardiol; 1994; 1(3):225-35. PubMed ID: 9420705
[TBL] [Abstract][Full Text] [Related]
48. In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62.
Mathias CJ; Welch MJ; Green MA; Diril H; Meares CF; Gropler RJ; Bergmann SR
J Nucl Med; 1991 Mar; 32(3):475-80. PubMed ID: 2005455
[TBL] [Abstract][Full Text] [Related]
49. A new generator for ionic gallium-68.
Loc'h C; Mazièré B; Comar D
J Nucl Med; 1980 Feb; 21(2):171-3. PubMed ID: 6965408
[TBL] [Abstract][Full Text] [Related]
50. Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging.
Lewis JS; Connett JM; Garbow JR; Buettner TL; Fujibayashi Y; Fleshman JW; Welch MJ
Cancer Res; 2002 Jan; 62(2):445-9. PubMed ID: 11809694
[TBL] [Abstract][Full Text] [Related]
51. 62Cu-labeled bifunctional radiopharmaceuticals with metabolizable ester groups.
Matsumoto K; Fujibayashi Y; Arano Y; Wada K; Yokoyama A
Int J Rad Appl Instrum B; 1992 Jan; 19(1):33-8. PubMed ID: 1577612
[TBL] [Abstract][Full Text] [Related]
52. 110Sn/110In--a new generator system for positron emission tomography.
Lundqvist H; Scott-Robson S; Einarsson L; Malmborg P
Int J Rad Appl Instrum A; 1991; 42(5):447-50. PubMed ID: 1646190
[TBL] [Abstract][Full Text] [Related]
53. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
[TBL] [Abstract][Full Text] [Related]
54. Effects of ischemia-reperfusion injury on myocardial single pass extraction and retention of Cu-PTSM in perfused rat hearts: comparison with 201T1 and 14C-iodoantipyrine.
Wada K; Fujibayashi Y; Taniuchi H; Tajima N; Tamaki N; Konishi J; Yokoyama A
Nucl Med Biol; 1994 May; 21(4):613-7. PubMed ID: 9234318
[TBL] [Abstract][Full Text] [Related]
55. Copper radionuclides and radiopharmaceuticals in nuclear medicine.
Blower PJ; Lewis JS; Zweit J
Nucl Med Biol; 1996 Nov; 23(8):957-80. PubMed ID: 9004284
[TBL] [Abstract][Full Text] [Related]
56. Structural characterization of a metal-based perfusion tracer: copper(II) pyruvaldehyde bis(N4-methylthiosemicarbazone).
John E; Fanwick PE; McKenzie AT; Stowell JG; Green MA
Int J Rad Appl Instrum B; 1989; 16(8):791-7. PubMed ID: 2621114
[TBL] [Abstract][Full Text] [Related]
57. The zinc-62/copper-62 generator: a convenient source of copper-62 for radiopharmaceuticals.
Robinson GD; Zielinski FW; Lee AW
Int J Appl Radiat Isot; 1980 Feb; 31(2):111-6. PubMed ID: 7364499
[No Abstract] [Full Text] [Related]
58. Correlation of Cu(PTSM) localization with regional blood flow in the heart and kidney.
Barnhart AJ; Voorhees WD; Green MA
Int J Rad Appl Instrum B; 1989; 16(7):747-8. PubMed ID: 2613532
[TBL] [Abstract][Full Text] [Related]
59. Enhancement of chromosomal aberrations in tumor cells with a non-labeled Cu-PTSM and irradiation with Cu K-shell monochromatic X rays.
Takakura K; Yaguchi S; Kanansugi Y; Kobayashi K; Okayasu R; Fujibayashi Y
Radiat Prot Dosimetry; 2006; 122(1-4):188-94. PubMed ID: 17234644
[TBL] [Abstract][Full Text] [Related]
60. Radionuclides and radiopharmaceuticals for single-photon emission tomography, positron emission tomography and radiotherapy in Russia.
Krasikova RN; Kodina GE
Eur J Nucl Med; 1999 Jul; 26(7):774-88. PubMed ID: 10398826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
